Home/Filings/4/0000950170-25-032273
4//SEC Filing

Moran Kevin Patrick 4

Accession 0000950170-25-032273

CIK 0001347178other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 4:45 PM ET

Size

5.5 KB

Accession

0000950170-25-032273

Insider Transaction Report

Form 4
Period: 2025-03-01
Moran Kevin Patrick
SVP, CFO & Treasurer
Transactions
  • Tax Payment

    Common Stock

    2025-03-01$4.76/sh26,941$128,239328,822 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    635
Footnotes (1)
  • [F1]Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs.

Documents

1 file

Issuer

Vanda Pharmaceuticals Inc.

CIK 0001347178

Entity typeother

Related Parties

1
  • filerCIK 0001806596

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:45 PM ET
Size
5.5 KB